Breaking News Instant updates and real-time market news.

ADPT

Adaptive Biotechnologies

$37.72

0.72 (1.95%)

, BCSF

Bain Capital Specialty Finance

$18.05

-0.15 (-0.82%)

08:30
07/11/19
07/11
08:30
07/11/19
08:30

Five new option listings on July 11th

New option listings for July 11th include Adaptive Biotechnologies Corporation (ADPT), Bain Capital Specialty Finance Inc (BCSF), IAA Inc (IAA), Joint Corp. (JYNT), and SI BONE Inc (SIBN).

ADPT

Adaptive Biotechnologies

$37.72

0.72 (1.95%)

BCSF

Bain Capital Specialty Finance

$18.05

-0.15 (-0.82%)

IAA

IAA

$40.00

-0.415 (-1.03%)

JYNT

Joint Corp.

$18.99

0.08 (0.42%)

SIBN

SI-Bone

$19.94

0.51 (2.62%)

  • 08

    Aug

  • 08

    Aug

  • 09

    Sep

  • 12

    Sep

ADPT Adaptive Biotechnologies
$37.72

0.72 (1.95%)

BCSF Bain Capital Specialty Finance
$18.05

-0.15 (-0.82%)

12/11/18
JANY
12/11/18
INITIATION
Target $21
JANY
Buy
Bain Capital Specialty Finance initiated with a Buy at Janney Montgomery Scott
Janney Montgomery Scott analyst Mitchel Penn started Bain Capital Specialty Finance with a Buy rating and $21 fair value estimate.
12/10/18
SBSH
12/10/18
INITIATION
SBSH
Neutral
Bain Capital Specialty Finance initiated with a Neutral at Citi
Citi started Bain Capital Specialty Finance with a Neutral rating.
12/10/18
FBCO
12/10/18
INITIATION
Target $20.5
FBCO
Outperform
Bain Capital Specialty Finance initiated with an Outperform at Credit Suisse
Credit Suisse analyst Douglas Harter started coverage of Bain Capital Specialty Finance with an Outperform rating and $20.50 price target. The analyst cited strong sponsorship from the external manager and an improving ROE combined with the 8.0% expected DY results in a 20.7% TR opportunity over the coming 12 months.
04/24/19
JMPS
04/24/19
INITIATION
JMPS
Market Perform
Bain Capital Specialty Finance initiated with a Market Perform at JMP Securities
JMP Securities analyst Christopher York initiated Bain Capital Specialty Finance with a Market Perform rating, stating that he views it as "thoughtfully constructed" and "superior to other BDC JVs," but he also believes the shares already reflect an appropriate premium and expected dividend growth.
IAA IAA
$40.00

-0.415 (-1.03%)

07/01/19
SPHN
07/01/19
INITIATION
Target $45
SPHN
Overweight
IAA initiated with an Overweight at Stephens
Stephens analyst Daniel Imbro initiated IAA (IAA) with an Overweight rating and $45 price target following the completion of the company's spinout from KAR Auction Services (KAR). He favors the company's exposure to the salvage industry and sees IAA being well-positioned to continue its solid growth, adding that he thinks its guidance is achievable and Street estimates "look beatable."
07/02/19
GUGG
07/02/19
DOWNGRADE
Target $20
GUGG
Sell
KAR Auction downgraded to Sell after IAA spinoff at Guggenheim
As previously reported, Guggenheim analyst Ali Faghri downgraded KAR Auction (KAR) to Sell from Neutral following the company's completion of its spinoff of IAA (IAA), citing his view of the cyclical headwinds for industry wholecar volume growth, increasing online competition, slower AFC growth due to declining industry physical auction volumes and higher loan loss provisions and downside risk to guidance. He set a $20 price target on KAR shares. Separately, Faghri initiated coverage of IAA with a Buy rating and $48 price target this morning.
07/02/19
GUGG
07/02/19
INITIATION
Target $48
GUGG
Buy
IAA initiated with a Buy at Guggenheim
Guggenheim analyst Ali Faghri initiated IAA (IAA) with a Buy rating and $48 following the company's completion of its spinoff from KAR Auction (KAR). Faghri sees the salvage market as a duopoly with pricing power and high barriers to entry and sees the valuation gap with Copart (CPRT) narrowing. He also sees IAA having a long-term margin improvement opportunity of 300-400 basis points, driven by reducing physical auctions and various cost savings initiatives. Separately, Faghri downgraded KAR Auction to Sell from Neutral this morning.
07/08/19
BRRR
07/08/19
INITIATION
Target $43
BRRR
Market Perform
IAA initiated with a Market Perform at Barrington
Barrington analyst Gary Prestopino started IAA (IAA) with a Market Perform rating and $43 price target. The analyst believes IAA is fairly valued at a current 20% discount to Copart (CPRT). However, as the company successfully executes on its growth and margin improvement initiatives, this discount can narrow over time to 10% or less, Prestopino tells investors in a research note.
JYNT Joint Corp.
$18.99

0.08 (0.42%)

05/23/19
DADA
05/23/19
NO CHANGE
Target $21
DADA
Buy
Joint Corp. weakness on short report a buying opportunity, says DA Davidson
DA Davidson analyst Michael Kawamoto recommends buying shares of Joint Corp. on the weakness in the stock caused by a short report with several accusations and negative assertions that he refutes. The report cites Joint's lower than average cost per visit as bearish, but the company prides itself on being a low cost solution and he does not see what point is being made. The report also cites the company as being unprofitable, and while acknowledging the model has taken time to ramp, Kawamoto said he expects significant leverage over the next several years. Additionally, the short report's analysis of break even is "comparing apples to oranges," said the analyst, who keeps a Buy rating and $21 price target on Joint Corp. shares.
06/20/19
RILY
06/20/19
INITIATION
Target $23
RILY
Buy
Joint Corp. initiated with a Buy at B. Riley FBR
B. Riley FBR started Joint Corp. with a Buy rating and $23 price target.
04/05/19
DADA
04/05/19
NO CHANGE
Target $20
DADA
Buy
Joint Corp price target raised to $20 from $15 at DA Davidson
DA Davidson analyst Michael Kawamoto raised his price target on Joint Corp to $20 and kept his Buy rating after hosting the company's CEO and CFO for investor meetings. The analyst says the discussions added to his confidence in the company's "ability to execute its growth strategy and continue to build brand awareness. " Kawamoto also points to Joint Corp's 3-year stacked comps growth of 72% thanks to its "significant first mover advantage" and he expects those trends to continue, with added scale translating into "significant margin expansion and earnings growth".
06/03/19
ROTH
06/03/19
NO CHANGE
Target $23
ROTH
Buy
Joint Corp. price target raised to $23 from $16 at Roth Capital
Roth Capital analyst David Bain raised his price target for Joint Corp. to $23 from $16, while reiterating a Buy rating on the shares. The analyst believes shares should be worth about $34 over the next 24-months.
SIBN SI-Bone
$19.94

0.51 (2.62%)

11/12/18
ADAM
11/12/18
INITIATION
Target $25
ADAM
Buy
SI-Bone initiated with a Buy at Canaccord
Canaccord analyst Kyle rose initiated SI-Bone with a Buy rating as he believes it has the potential to be a classic small-cap me-tech execution story underpinned by an established technology, large addressable market, exceptional gross margin profile and best-in-class clinical data. Rose has a $25 price target on SI-Bone shares.
11/12/18
MSCO
11/12/18
INITIATION
Target $24
MSCO
Overweight
SI-Bone initiated with an Overweight at Morgan Stanley
Morgan Stanley analyst David Lewis started SI-Bone with an Overweight rating and $24 price target, stating that SI joint fusion could be the "next major orthopedic joint procedure" and that the company's clinically differentiated implant, iFuse, is uniquely positioned to penetrate this significantly underserved market. He also contends the company's unique model is more scalable and profitable than peers, Lewis tells investors.
11/12/18
BOFA
11/12/18
INITIATION
Target $23
BOFA
Buy
SI-Bone initiated with a Buy at BofA/Merrill
BofA Merrill Lynch analyst Bob Hopkins initiated SI-Bone with a Buy rating and $23 price target, stating that he believes the company has the tools, the clinical data, payor coverage and capital to develop iFuse as the standard of care for treating sacroiliac, or SI, joint pain.
11/12/18
11/12/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Denali Therapeutics (DNLI) initiated with a Buy at Janney Montgomery Scott. 2. PhaseBio (PHAS) initiated with a Buy at Stifel and Citi as well as an Outperform at Cowen. 3. Osmotica Pharmaceuticals (OSMT) initiated with a Buy at Jefferies as well as an Outperform at Wells Fargo and RBC Capital. 4. SI-Bone (SIBN) initiated with an Outperform at JMP Securities, an Overweight at Morgan Stanley, as well as a Buy at Canaccord and BofA/Merrill. 5. Studio City (MSC) initiated with an Underweight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

ASOMY

Asos

$0.00

(0.00%)

21:13
07/21/19
07/21
21:13
07/21/19
21:13
Downgrade
Asos rating change at JPMorgan »

Asos downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KLAC

KLA-Tencor

$131.95

-1.5 (-1.12%)

21:12
07/21/19
07/21
21:12
07/21/19
21:12
Upgrade
KLA-Tencor rating change at Goldman Sachs »

KLA-Tencor upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Aug

LRCX

Lam Research

$198.43

0.19 (0.10%)

21:07
07/21/19
07/21
21:07
07/21/19
21:07
Upgrade
Lam Research rating change at Goldman Sachs »

Lam Research upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

MRVL

Marvell

$25.90

-0.48 (-1.82%)

21:07
07/21/19
07/21
21:07
07/21/19
21:07
Downgrade
Marvell rating change at Goldman Sachs »

Marvell downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMAT

Applied Materials

$47.79

-0.38 (-0.79%)

21:05
07/21/19
07/21
21:05
07/21/19
21:05
Upgrade
Applied Materials rating change at Goldman Sachs »

Applied Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$45.51

0.85 (1.90%)

21:04
07/21/19
07/21
21:04
07/21/19
21:04
Upgrade
Goldman Sachs more positive on memory stocks, upgrades Micron to Buy »

Goldman Sachs analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEYS

Keysight Technologies

$87.43

0.05 (0.06%)

20:49
07/21/19
07/21
20:49
07/21/19
20:49
Downgrade
Keysight Technologies rating change at Goldman Sachs »

Keysight Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BYND

Beyond Meat

$176.65

6.28 (3.69%)

, TGT

Target

$88.02

-0.48 (-0.54%)

19:30
07/21/19
07/21
19:30
07/21/19
19:30
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

BYND

Beyond Meat

$176.65

6.28 (3.69%)

TGT

Target

$88.02

-0.48 (-0.54%)

DIS

Disney

$139.86

-1.76 (-1.24%)

NFLX

Netflix

$315.10

-10.04 (-3.09%)

T

AT&T

$32.77

-0.32 (-0.97%)

CBS

CBS

$50.68

-0.66 (-1.29%)

FDX

FedEx

$167.08

1.69 (1.02%)

EFX

Equifax

$137.29

-2 (-1.44%)

KEY

KeyCorp

$17.45

0.15 (0.87%)

SBNY

Signature Bank

$123.87

1.07 (0.87%)

USB

U.S. Bancorp

$54.98

-0.2 (-0.36%)

MA

MasterCard

$275.51

-1.11 (-0.40%)

V

Visa

$179.18

-1.34 (-0.74%)

PYPL

PayPal

$118.65

-1.22 (-1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 23

    Jul

  • 24

    Jul

  • 24

    Jul

  • 29

    Jul

  • 30

    Jul

  • 30

    Jul

  • 30

    Jul

  • 31

    Jul

  • 03

    Aug

  • 06

    Aug

  • 06

    Aug

  • 08

    Aug

  • 08

    Aug

  • 12

    Aug

  • 21

    Aug

  • 29

    Aug

  • 17

    Sep

  • 19

    Sep

  • 25

    Sep

  • 16

    Oct

  • 13

    Nov

T

AT&T

$32.77

-0.32 (-0.97%)

, CMCSA

Comcast

$44.06

-0.5 (-1.12%)

18:23
07/21/19
07/21
18:23
07/21/19
18:23
On The Fly
Box Office Battle: 'The Lion King' roars to number 1 in $185M U.S. debut »

"Box Office Battle" is…

T

AT&T

$32.77

-0.32 (-0.97%)

CMCSA

Comcast

$44.06

-0.5 (-1.12%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$53.68

-0.275 (-0.51%)

LGF.A

Lionsgate

$11.94

0.36 (3.11%)

DIS

Disney

$139.86

-1.76 (-1.24%)

VIAB

Viacom

$30.48

-0.11 (-0.36%)

VIA

Viacom

$35.24

0.24 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 30

    Jul

  • 30

    Jul

  • 06

    Aug

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

EFX

Equifax

$137.29

-2 (-1.44%)

17:23
07/21/19
07/21
17:23
07/21/19
17:23
Periodicals
Equifax agrees to pay $700M after massive data breach, WSJ reports »

Equifax is nearing a deal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 06

    Aug

  • 12

    Aug

  • 13

    Nov

CBS

CBS

$50.68

-0.66 (-1.29%)

, T

AT&T

$32.77

-0.32 (-0.97%)

17:17
07/21/19
07/21
17:17
07/21/19
17:17
Periodicals
AT&T drops CBS channels from cable systems, Reuters reports »

CBS (CBS) and AT&T…

CBS

CBS

$50.68

-0.66 (-1.29%)

T

AT&T

$32.77

-0.32 (-0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 30

    Jul

  • 08

    Aug

  • 08

    Aug

NFLX

Netflix

$315.10

-10.04 (-3.09%)

17:11
07/21/19
07/21
17:11
07/21/19
17:11
Periodicals
Netflix signs first direct agreement with SAG-AFTRA, Bloomberg reports »

Netflix and the Screen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

JNJ

Johnson & Johnson

$130.41

-1.62 (-1.23%)

17:08
07/21/19
07/21
17:08
07/21/19
17:08
Periodicals
Johnson & Johnson facing key test in talc-safety lawsuits, WSJ reports »

Johnson & Johnson,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 16

    Sep

  • 15

    Oct

MRKR

Marker Therapeutics

$6.28

-2.4 (-27.65%)

16:46
07/21/19
07/21
16:46
07/21/19
16:46
Hot Stocks
Marker Therapeutics reports interim results of MultiTAA T Cell Therapy »

Marker Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 09

    Sep

RDY

Dr. Reddy's

$37.73

-0.6 (-1.57%)

16:41
07/21/19
07/21
16:41
07/21/19
16:41
Hot Stocks
Dr. Reddy's announces transaction closure to divest Zembrace Symtouch, Tosymra »

Dr. Reddy's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jul

KLAC

KLA-Tencor

$131.95

-1.5 (-1.12%)

16:37
07/21/19
07/21
16:37
07/21/19
16:37
Upgrade
KLA-Tencor rating change at Goldman Sachs »

KLA-Tencor upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Aug

LRCX

Lam Research

$198.43

0.19 (0.10%)

16:33
07/21/19
07/21
16:33
07/21/19
16:33
Upgrade
Lam Research rating change at Goldman Sachs »

Lam Research upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

MRVL

Marvell

$25.90

-0.48 (-1.82%)

16:30
07/21/19
07/21
16:30
07/21/19
16:30
Downgrade
Marvell rating change at Goldman Sachs »

Marvell downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEYS

Keysight Technologies

$87.43

0.05 (0.06%)

16:29
07/21/19
07/21
16:29
07/21/19
16:29
Downgrade
Keysight Technologies rating change at Goldman Sachs »

Keysight Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$45.51

0.85 (1.90%)

16:26
07/21/19
07/21
16:26
07/21/19
16:26
Upgrade
Micron rating change at Goldman Sachs »

Micron upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCEHY

Tencent

$0.00

(0.00%)

, MDLA

Medallia

$37.09

(0.00%)

07:31
07/21/19
07/21
07:31
07/21/19
07:31
On The Fly
Opening Day: Start-up DouYou becomes China's biggest Wall Street IPO of 2019 »

Drugmaker Genmab raised…

TCEHY

Tencent

$0.00

(0.00%)

MDLA

Medallia

$37.09

(0.00%)

MIRM

Mirum Pharmaceuticals

$13.51

0.17 (1.27%)

FULC

Fulcrum Therapeutics

$12.49

-0.99 (-7.34%)

PHR

Phreesia

$24.01

-1.15 (-4.57%)

GMAB

Genmab

$18.06

-0.14 (-0.77%)

AMK

AssetMark Financial

$27.71

0.39 (1.43%)

ORCC

Owl Rock

$15.51

0.11 (0.71%)

DOYU

DouYu

$10.50

-0.51 (-4.63%)

NOVA

Sunnova Energy

$0.00

(0.00%)

CSTL

Castle Biosciences

$0.00

(0.00%)

WSG

Wanda Sports

$0.00

(0.00%)

LVGO

Livongo Health

$0.00

(0.00%)

HCAT

Health Catalyst

$0.00

(0.00%)

JNJ

Johnson & Johnson

$130.41

-1.62 (-1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 22

    Jul

  • 23

    Jul

  • 23

    Jul

  • 24

    Jul

  • 24

    Jul

  • 31

    Jul

  • 14

    Aug

  • 09

    Sep

  • 16

    Sep

  • 15

    Oct

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 26

    Jul

PYPL

PayPal

$118.65

-1.22 (-1.02%)

, V

Visa

$179.18

-1.34 (-0.74%)

08:31
07/20/19
07/20
08:31
07/20/19
08:31
Periodicals
MasterCard, Visa among best stocks to play fintech boom, Barron's says »

The fintech units within…

PYPL

PayPal

$118.65

-1.22 (-1.02%)

V

Visa

$179.18

-1.34 (-0.74%)

MA

MasterCard

$275.51

-1.11 (-0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 24

    Jul

  • 30

    Jul

USB

U.S. Bancorp

$54.98

-0.2 (-0.36%)

, SBNY

Signature Bank

$123.87

1.07 (0.87%)

08:28
07/20/19
07/20
08:28
07/20/19
08:28
Periodicals
KeyCorp, U.S. Bancorp better positioned for Fed rate cut, Barron's says »

KeyCorp (KEY), Signature…

USB

U.S. Bancorp

$54.98

-0.2 (-0.36%)

SBNY

Signature Bank

$123.87

1.07 (0.87%)

KEY

KeyCorp

$17.45

0.15 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 29

    Aug

  • 16

    Oct

CMG

Chipotle

$746.80

-17.43 (-2.28%)

08:24
07/20/19
07/20
08:24
07/20/19
08:24
Periodicals
Chipotle stock made 'stunning' comeback, Barron's says »

Chipotle's stock is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 25

    Sep

BYND

Beyond Meat

$176.65

6.28 (3.69%)

07:40
07/20/19
07/20
07:40
07/20/19
07:40
Periodicals
Beyond Meat could spike after earnings, Barron's says »

After rising so…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.